CliniSys Hires Mark Spencer as Senior Vice President of Global Strategy

CliniSys GroupCliniSys announced that Mark Spencer has joined the company as Senior Vice President of Global Strategy. A 25-year veteran in the life sciences and healthcare IT industry, Mark will be charged with driving growth globally.

As the world looks to improve public health now and after the pandemic, Mark will work closely with the senior leadership team to realise CliniSys' vision to support its customers both inside and beyond the walls of the clinical laboratory to embrace a new wave of community laboratories and digital diagnostics in healthcare, toxicology, agriculture, water and environmental testing.

The appointment follows CliniSys' recent acquisition of HORIZON Lab Systems and merger with Sunquest Information Systems. Mark will play a critical role in integrating these business lines and product offerings to help organisations and governments globally better fight disease.

"CliniSys is at an exciting stage of growth after its recent M&A activity, priming it to deliver the integrated and holistic laboratory diagnostics that will drive the next wave of innovation in disease surveillance and tracking," said Mark Spencer. "That is why I am looking forward to returning to the company and driving the strategies that will accelerate our growth in key regions globally."

A former manager at Sunquest, Mark rejoins from Abbott Informatics, where he led the successful growth of its former laboratory information management system (STARLIMS). Mark began his career in the military, serving six years as a management engineer in the United States Air Force.

"Mark brings with him a deep knowledge of healthcare and technology, and a wealth of experience leading an impressive list of successful business transformations in the sector," said CliniSys CEO Michael Simpson. "We are delighted to have him on board for this next stage in our growth."

About CliniSys

CliniSys, headquartered in Chertsey, England and Tucson, Arizona, is one of the largest provider of laboratory information systems, order entry and result consultation, and public health solutions in disease surveillance and outbreak management across the United Kingdom, Europe, and the United States. For 40 years, successfully specialising in complex and the wide scale delivery of comprehensive laboratory and public health solutions in over 3,000 laboratories across 34 countries using CliniSys solutions.

Our combined cross-discipline expertise provides customers with solutions to support laboratory workflow across clinical, histology, molecular, genetics, including order management, reporting and results delivery. Additionally, we serve laboratories in environmental testing, water quality, agriculture, and toxicology.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...